UNSPSC 51352206: Diethylstilbestrol dipalmitate

This classification denotes a non-steroidal estrogen with the molecular formula C50H80O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 86291XW83U, chemically known as hexadecanoic acid, (1,2-diethyl-1,2-ethenediyl)di-4,1-phenylene ester, (e)-, but more generally known as diethylstilbestrol dipalmitate, which bears US NIH Compound Identifier 3032511. European Medicines Agency schedules diethylstilbestrol dipalmitate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07112MIG.

Most nations, for tariff purposes, schedule diethylstilbestrol dipalmitate under HS 29072900. SMILES: CCCCCCCCCCCCCCCC(=O)OC1CCC(CC1)/C(=C(\CC)/C2CCC(CC2)OC(=O)CCCCCCCCCCCCCCC)/CC.

UNSPSC 51352206 Diethylstilbestrol dipalmitate is a Commodity code that captures procurement of this specific pharmaceutical compound, a synthetic estrogen derivative historically used in veterinary and human medical applications. State and local governments procure diethylstilbestrol dipalmitate primarily through health departments, correctional health services, and veterinary control agencies for limited clinical and research purposes; however, the compound's restricted regulatory status in most U.S. jurisdictions has substantially narrowed its procurement footprint. The issuing bodies soliciting under this code are typically state health agencies and corrections departments with clinical or laboratory functions, and purchasing occurs on an as-needed basis rather than through routine contract vehicles.

No recent state and local contract opportunities appear in the available records for this code. The narrow clinical application and regulatory restrictions on diethylstilbestrol dipalmitate use mean procurement activity, when it occurs, is infrequent and often handled through standing pharmaceutical supply agreements or direct negotiation rather than public notice. Firms seeking work under this code should monitor health department and corrections RFPs at the state level, particularly in jurisdictions maintaining legacy pharmaceutical stockpiles or conducting historical medical research, but should not expect regular solicitation activity.